Sharon E. Cain, MD
Professor, Psychiatry and Behavioral Sciences
Director, Director for the Division of Child and Adolescent Psychiatry , Psychiatry and Behavioral Sciences
Program Director, Program Director for the Child and Adolescent Psychiatry Fellowship, Psychiatry and Behavioral Sciencesscain@kumc.edu
Dr. Sharon Cain is Professor of Psychiatry at the University of Kansas Medical Center and Division Director of Child Psychiatry in the Department of Psychiatry and Behavioral Sciences. Dr. Cain has also been the Program Director for the Child and Adolescent Psychiatry Fellowship Program for more than twenty years.
Dr. Cain received her medical degree and completed a psychiatry residency and a child psychiatry fellowship, all at the University of Kansas Medical Center. After completing the fellowship, she practiced in the Kansas City area for 10 years prior to returning to the KU medical Center and Joining the Psychiatry faculty. Since then she has focused on expanding the the child psychiatry fellowship and developing child psychiatry and community relationships.
Education and Training
- MD, Psychiatry, Univ. of Kansas-Medical Ctr.
- Clinical Fellowship, Child and Adolescent Psychiatry, University of Kansas School of Medicine, Kansas City, KS
Licensure, Accreditations & Certifications
- Medical license, Kansas State Board of Healing Arts
- Neuroscience Education Institute (NEI), Member, 2015 - Present
- American Telemedicine Association (ATA), Member, 2002 - Present
- American Academy of Child and Adolescent Psychiatry (AACAP), Member, 1990 - Present
Dr. Cain is Professor of Psychiatry at the University of Kansas Medical Center and Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry.
Her research interests have focused on telepsychiatry for children and adolescents, the delivery of psychiatric care to youth via telemedicine. Her publications have included the original practice parameter on Telepsychiatry for youth and a book chapter on Telehealth in a major textbook on child and adolescent psychiatry.
Another area of research interest is participating in clinical psychopharmacology studies in youth, to better understand the safety and efficacy of medications.
Current Research and Grants
- 1. A Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial to Evaluate the Efficacy of Brexpiprazole Monotherapy for the Treatment in Adolescents (13-17 years old) With Schizophrenia., Syneos Health, PI
- Cain, Sharon, Myers, Kathleen, Nelson, Eve-lynn. 2016. Telemental Health
- Cain, Sharon, Sharp, Susan. 2016. Telepharmacotherapy for Child and Adolescent Psychiatric Patients. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 26 (3), 221-228
- Kaftarian, E., L, Caudill, R., L, Kim, T, Lingham, H, Antoniotti, M, Rabinowitz, T, Myers, K, Yellowlees, P., M, Nelson, Eve-Lynn, Cain, Sharon., E, Wright, S, Hilty, Don., M. 2019. Kaftarian EL, Caudill RL, Kim T, Lingam H, Antoniotti M, Rabinowitz T, Myers K, Yellowlees PM, Nelson EL, Cain SE, Wright S, Hilty DM. Online Prescribing of Controlled Substances for Mental Health Issues: A View of the Current Landscape . Journal of Technology in Behavioral Science, 4 (3), 285-296